Nephron Pharmaceuticals Corporation dba Nephron Sterile Compounding Center

Form 483

South Carolina, United StatesFEI 3011158388Issued May 30, 2018

View Form 483 PDF

Source: FDA, document on file. FDA released the Form 483 itself. The document linked above is our copy of FDA's file, stored by us so the link cannot break, and FDA's own copy is linked beside it. To check it, open FDA's record for this establishment on FDA's Data Dashboard, listed under FEI 3011158388.

Observations1

Issue DateMay 30, 2018

StatusNo Warning Letter

Establishment TypeOutsourcing Facility

Related Inspections0

Establishment Details

Firm: Nephron Pharmaceuticals Corporation dba Nephron Sterile Compounding Center
Location: South Carolina, United States
FEI Number: 3011158388
Establishment Type: Outsourcing Facility
Product Type: Outsourcing Facility
Issue Date: May 30, 2018
Country: United States

Inspection History

We hold no FDA inspection matched to this establishment.

Act on This Form 483

FDA Inspection ReadinessSee how your operations would hold up to the same scrutiny.CAPA & InvestigationsScore how you would investigate and close findings like these.Talk to a SpecialistWalk through these observations with a ComplianceQuest expert.

Nephron Pharmaceuticals Corporation dba Nephron Sterile Compounding Center FDA Form 483, South Carolina, May 30, 2018